Kessler Medical Rehabilitation Research and Education Corporation Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2003
NCT00142402
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2003

Timeline

NOW
  • Now

Alternative names

KMRREC

Active Ingredients

Drugs in Other Trials (1)

modafinil (provigil) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1